Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

2Likes

128Views

Nov 272024

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry, including GLP-1s, consolidation in the CDMO sector, and sterile fill-finish. He tells us more about Piramal’s $80-million expansion in Kentucky and how the company is adapting to the changes in the market. Check out the video! --------------------- Read more of our articles here: https://themedicinemaker.com/ Sign up for free digital & physical copies here: https://themedicinemaker.com/login/si... This film was created by Texere Video Production. To find out more visit our website. To discuss your own video needs contact our team at video@texerepublishing.com Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP Press the bell button to receive notifications whenever we post a new video. Follow us and access our latest content: Twitter: https://bit.ly/3C3coWV Facebook: https://bit.ly/3vBcBye Linkedin: https://bit.ly/3vKTulr Instagram: https://bit.ly/3jlzOPK Website: https://bit.ly/30MUQR8 To follow what we are doing at Texere follow us: Twitter: https://bit.ly/3nfDZ0P Facebook: https://bit.ly/3AZ9fWI Linkedin: https://bit.ly/3b1ZHj6 Instagram: https://bit.ly/3E8BoMO Website: https://bit.ly/3B51GxG